Fortrea Holdings FTRE
NASDAQ FTRE
$16.79 -0.27 (-1.58%)
As of: Sep 9, 2026 · 3:59 PM EDT

Fortrea Holdings (FTRE) Non-Current Deferred Tax Liability (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Non-Current Deferred Tax Liability came in at $97.0 million in Q2 2026, down 14.01% on a YoY basis from $112.8 million in Q2 2025, and up 5.09% quarter-over-quarter from $92.3 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Non-Current Deferred Tax Liability (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has reported Non-Current Deferred Tax Liability for 5 consecutive years, with $97.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non-Current Deferred Tax Liability fell 14.01% year-over-year to $97.0 million; the trailing twelve-month figure through Jun 2026 stood at $97.0 million (down 14.01% YoY), and the FY2025 full-year result was $97.6 million, down 19.8% from the prior year.
  • Non-Current Deferred Tax Liability improved to $97.0 million in Q2 2026 per FTRE's latest filing, from $92.3 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $184.5 million in Q4 2022 and bottomed at $92.3 million in Q1 2026.
  • Historically, Non-Current Deferred Tax Liability has averaged $132.0 million across 5 years, with a median of $124.3 million in 2024.
  • The sharpest annual moves came in 2024 and 2026: Non-Current Deferred Tax Liability slipped 26.11% in 2024, then declined 14.01% in 2026.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $184.5 million in 2022, then fell by 19.95% to $147.7 million in 2023, then decreased by 17.6% to $121.7 million in 2024, then decreased by 19.8% to $97.6 million in 2025, then slipped by 0.61% to $97.0 million in 2026.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $97.0 million, $92.3 million, and $97.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn
6 Evotec SE 661.34 Mn 235.46 Mn -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn
10 VivoSim Labs 1.47 Mn 1.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 97.00 Mn
Mar 31, 2026 92.30 Mn
Dec 31, 2025 97.60 Mn
Sep 30, 2025 106.90 Mn
Jun 30, 2025 112.80 Mn
Mar 31, 2025 117.90 Mn
Dec 31, 2024 121.70 Mn
Sep 30, 2024 126.90 Mn
Jun 30, 2024 136.10 Mn
Mar 31, 2024 150.70 Mn
Dec 31, 2023 147.70 Mn
Sep 30, 2023 171.70 Mn
Jun 30, 2023 184.20 Mn
Dec 31, 2022 184.50 Mn